Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061544) titled 'Telehealth in specialist palliative care in patients with advanced lung cancer: A randomized controlled trial' on June 1.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - Nagoya University

Condition: Condition - Advanced Lung Cancer (advanced non-small-cell or advanced small-cell lung cancer) Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To evaluate the efficacy of a telehealth palliative care intervention compared with usual care in improving quality of life (FACT-L total score) at 12 weeks in patients with advanced lung cancer. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Patients in the intervention group will receive telehealth palliative care consultations at baseline and at 4, 8, and 12 weeks. Interventions/Control_2 - Patients will receive standard oncological care from their treating physicians. Access to face-to-face specialist palliative care at their own institution is not restricted if deemed necessary by the treating physician or requested by the patient.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - -Aged 18 years or older. -Currently receiving anti-cancer therapy* at a participating institution. * Including cytotoxic chemotherapy, targeted therapy, and immune checkpoint inhibitors. -Estimated life expectancy of at least 6 months, as determined by the treating physician. -Diagnosed with advanced* non-small cell lung cancer (NSCLC) or advanced* small cell lung cancer (SCLC). * Definition of advanced disease: NSCLC (Stage III/IV) not eligible for curative-intent treatment (surgery or radiotherapy); or SCLC (extensive-stage, limited-stage ineligible for radiotherapy, or recurrent disease). -Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3. -Able to communicate and respond to questions in Japanese. Key exclusion criteria - -Prior receipt of specialist palliative care.* *Defined as having two or more previous visits to a palliative care outpatient clinic. -Inability to operate a tablet or similar device, lack of a home internet connection, or difficulty accessing the standardized online platform for online palliative care consultations, as determined by the treating physician. -Considered unsuitable for study participation by the treating physician due to psychiatric condition or cognitive function. Target Size - 90

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 04 Month 30 Day Anticipated trial start date - 2026 Year 07 Month 01 Day Last follow-up date - 2027 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069520

Disclaimer: Curated by HT Syndication.